Clinical Trial Update: Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML [Phase 1, Phase 2]

View source ↗

Summary

Pilot study results for crenolanib combined with salvage chemotherapy in relapsed/refractory acute myeloid leukemia (AML) reported in a Phase 1/Phase 2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Crenolanib (Crenolanib)

Snippet

Sponsor: Arog Pharmaceuticals, Inc. | Conditions: Relapsed/Refractory Acute Myeloid Leukemia (AML) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-20